New study aims to improve Pre-Surgery treatment for aggressive breast cancer

NCT ID NCT07523789

First seen Apr 17, 2026 · Last updated May 08, 2026 · Updated 4 times

Summary

This study looks back at medical records of 201 people with triple-negative breast cancer who received chemotherapy or immunotherapy before surgery. The goal is to see which treatment leads to a complete disappearance of cancer in the breast and lymph nodes, and what factors affect this outcome. Participants must be 18 or older, have completed pre-surgery treatment, and have had surgery afterward.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • the First Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.